IRIS
BITTONI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.887
EU - Europa 1.330
AS - Asia 980
SA - Sud America 279
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.583
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.858
SG - Singapore 418
IT - Italia 267
BR - Brasile 243
CN - Cina 218
UA - Ucraina 199
SE - Svezia 168
DE - Germania 152
IE - Irlanda 118
RU - Federazione Russa 111
TR - Turchia 98
FI - Finlandia 86
DK - Danimarca 72
VN - Vietnam 72
CI - Costa d'Avorio 59
HK - Hong Kong 59
GB - Regno Unito 54
KR - Corea 39
FR - Francia 36
IN - India 30
NL - Olanda 26
MA - Marocco 23
JP - Giappone 19
AR - Argentina 14
BD - Bangladesh 12
CA - Canada 12
MX - Messico 12
PL - Polonia 10
ZA - Sudafrica 10
ES - Italia 9
BE - Belgio 8
EC - Ecuador 7
CO - Colombia 5
DZ - Algeria 5
ID - Indonesia 5
CZ - Repubblica Ceca 4
EU - Europa 3
VE - Venezuela 3
CL - Cile 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IQ - Iraq 2
KE - Kenya 2
LT - Lituania 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CR - Costa Rica 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 5.583
Salva come PNG Salva come JPEG
Città #
Ashburn 354
Chandler 286
Singapore 276
Jacksonville 214
Fairfield 210
Wilmington 135
Boardman 118
Dublin 118
Dallas 116
New York 107
Woodbridge 103
Ann Arbor 95
Seattle 94
Houston 91
Des Moines 74
Cambridge 72
Beijing 69
Centro 67
Abidjan 59
Hong Kong 59
Los Angeles 50
Lawrence 47
Munich 47
Princeton 47
San Mateo 47
The Dalles 37
Turin 33
Turku 33
Moscow 23
Buffalo 18
Ho Chi Minh City 18
San Diego 18
Tokyo 17
Hefei 16
London 16
Hanoi 15
Helsinki 15
Santa Clara 14
Atlanta 13
Stockholm 12
Chicago 11
Orem 11
São Paulo 11
Brooklyn 10
Pune 10
Rio de Janeiro 10
Chennai 9
Frankfurt am Main 9
Johannesburg 9
Rome 9
Amsterdam 8
Brussels 8
Poplar 8
Warsaw 8
Brasília 7
Curitiba 7
Denver 7
Guangzhou 7
Washington 7
Wuhan 7
Wuxi 7
Belo Horizonte 6
Biên Hòa 6
Cagliari 6
Fortaleza 6
Milan 6
Montreal 6
San Francisco 6
St Petersburg 6
Bogotá 4
Columbus 4
Falls Church 4
Haiphong 4
Manchester 4
Mexico City 4
Miami 4
Nanjing 4
New Bedfont 4
Nuremberg 4
Olomouc 4
Porto Alegre 4
Prescot 4
Salt Lake City 4
Shenzhen 4
Yiwu 4
Ancona 3
Betim 3
Campinas 3
Cupra Marittima 3
Dhaka 3
Fermignano 3
Florence 3
Guayaquil 3
Isola Rizza 3
Izmir 3
Jinan 3
Kilburn 3
Modena 3
Mumbai 3
New Delhi 3
Totale 3.590
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 177
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 168
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 167
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 159
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 157
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 152
Optimal management of resected gastric cancer 150
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 146
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 143
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 138
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 138
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 138
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 135
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 131
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 130
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 129
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 128
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 125
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 124
Medical treatment for cholangiocarcinoma 124
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 123
HER family receptor expression and prognosis in pancreatic cancer 121
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 120
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 118
Panitumumab for the treatment of metastatic colorectal cancer: A review 115
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 113
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 113
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 112
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 110
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 108
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 106
ASSOCIAZIONE TRA STATO MUTAZIONALE DI KRAS E PATTERN DI ESPRESSIONE GENETICA NEL CARCINOMA DEL PANCREAS 106
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 105
Trattamento del carcinoma del pancreas. Attualità e prospettive 104
Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity. 103
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 103
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 102
The challenge of targeted therapies for gastric cancer patients: The beginning of a long journey 97
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 97
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 95
Palliative treatment 93
Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: A new strategy to improve immunotherapy efficacy? 93
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 87
Selecting the best treatment for an individual patient. 79
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 78
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 76
Sicurezza degli ESA: sopravvivenza e stimolazione recettoriale/progressione tumorale 71
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 65
Totale 5.672
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021479 0 0 0 0 0 59 62 59 72 105 80 42
2021/2022389 29 94 6 8 5 29 17 23 17 54 29 78
2022/2023854 60 117 59 62 62 141 1 46 193 10 80 23
2023/2024501 74 8 45 61 69 131 5 20 3 8 10 67
2024/2025987 148 77 20 21 64 49 99 35 162 71 133 108
2025/20261.271 209 184 132 309 379 58 0 0 0 0 0 0
Totale 5.672